Publications by authors named "Sean D MacKnight"

Claim this Profile
E
Effects of adjunctive cariprazine formulary restrictions in major depressive disorder.
Nadia Nabulsi, François Laliberté, Enrico Zanardo, Sean D MacKnight, Sophie Ma

Am J Manag Care· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of rivaroxaban vs warfarin in patients with pulmonary embolism and right ventricular dysfunction: a retrospective cohort study.
François Laliberté, Behnood Bikdeli, Veronica Ashton, Guillaume Germain, Julien Boudreau, Sean D MacKnight

Res Pract Thromb Haemost· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductions in medical visits and hospitalizations following berotralstat initiation in patients with hereditary angioedema in the United States.
Sandra C Christiansen, Lorena Lopez-Gonzalez, Sean D MacKnight, François Laliberté, Colleen Spencer

J Manag Care Spec Pharm· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United States.
Sameer K Mathur, Jared Silver, Sean D MacKnight, Ana Urosevic, Cristina Martinez

Ann Allergy Asthma Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Assessment of All-Cause Hospital Readmissions among Pulmonary Embolism Patients Treated With Rivaroxaban Versus Apixaban.
Veronica Ashton, Guillaume Germain, Julien Boudreau, Manasvi Sundar, Sean D MacKnight

Clin Appl Thromb Hemost· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting.
Christoph U Correll, Andrew J Cutler, François Laliberté, Guillaume Germain, Sean D MacKnight

Ann Gen Psychiatry· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Exposure Prophylaxis for the Prevention of HIV-1: An Assessment of Oral Pre-Exposure Prophylaxis Usage Patterns, First Evidence of HIV-1, and HIV-1 Risk Factors in the United States.
Alan Oglesby, Guillaume Germain, Aimee A Metzner, François Laliberté, Sean D MacKnight

AIDS Patient Care STDS· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and costs associated with first versus subsequent use of cariprazine for bipolar I disorder.
Andrew J Cutler, François Laliberté, Guillaume Germain, Sean D MacKnight, Julien Boudreau

J Med Econ· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count.
Guillaume Germain, Karen Worley, Sean D MacKnight, Bernard Rubin, Christopher F Bell

Lupus Sci Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma.
Thomas B Casale, Thomas Corbridge, Guillaume Germain, François Laliberté, Sean D MacKnight

Allergy Asthma Clin Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of formulary-related pharmacy claim rejections of cariprazine on health care utilization and treatment patterns among patients with bipolar I disorder.
François Laliberté, Enrico Zanardo, Sean D MacKnight, Ana Urosevic, Sally W Wade

J Manag Care Spec Pharm· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management.
William W Busse, Carl B Abbott, Guillaume Germain, François Laliberté, Sean D MacKnight

J Allergy Clin Immunol Pract· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The real-world health resource use and costs of misdiagnosing bipolar I disorder.
Roger S McIntyre, François Laliberté, Guillaume Germain, Sean D MacKnight, Patrick Gillard

J Affect Disord· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States.
Carlyne M Averell, François Laliberté, Guillaume Germain, Mei Sheng Duh, Matthew D Rousculp, Sean D MacKnight

Ther Adv Respir Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study.
David Mannino, Michael Bogart, Benjamin Wu, Guillaume Germain, François Laliberté, Sean D MacKnight

Respir Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation.
David Mannino, Michael Bogart, Guillaume Germain, Shirley P Huang, Afisi S Ismaila, Sean D MacKnight

Int J Chron Obstruct Pulmon Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs of patients with cancer stratified by Khorana score risk levels.
Alok A Khorana, Nicole M Kuderer, Keith McCrae, Dejan Milentijevic, Guillaume Germain, Sean D MacKnight

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities.
Ravi Kalhan, David Slade, Riju Ray, Chad Moretz, Guillaume Germain, Sean Dale MacKnight

Int J Chron Obstruct Pulmon Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.
David Slade, Riju Ray, Chad Moretz, Guillaume Germain, François Laliberté, Sean D MacKnight

Pulm Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA.
François Laliberté, Monika Raut, Xiaoqin Yang, Guillaume Germain, Akash Nahar, Sean D MacKnight

Target Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US.
Dejan Milentijevic, Guillaume Germain, François Laliberté, Brahim K Bookhart, Sean D MacKnight

J Med Econ· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels.
Alok A Khorana, Nicole M Kuderer, Keith McCrae, Dejan Milentijevic, Guillaume Germain, Sean D MacKnight

Cancer Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking.
Graeme W Carlile, Renaud Robert, Julie Goepp, Elizabeth Matthes, Jie Liao, Sean D Macknight

J Cyst Fibros· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis